Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-28

Clinical Trial Update: Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating metronomic oral chemotherapy with cyclophosphamide, capecitabine, and vinorelbine in metastatic/metastatic breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Capecitabine (capecitabine)
  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: European Institute of Oncology | Conditions: Advanced Breast Cancer | Phase 2 | Status: UNKNOWN